Breaking News Instant updates and real-time market news.

TWTR

Twitter

$23.52

-0.48 (-2.00%)

, CRM

Salesforce

$72.63

2.11 (2.99%)

19:35
10/04/16
10/04
19:35
10/04/16
19:35

Twitter rises 3.7%, Salesforce dips 1% after report on bidding process

TWTR

Twitter

$23.52

-0.48 (-2.00%)

CRM

Salesforce

$72.63

2.11 (2.99%)

GOOG

Alphabet

$776.43

3.87 (0.50%)

GOOGL

Alphabet Class A

$802.79

2.41 (0.30%)

DIS

Disney

$92.59

0.1 (0.11%)

  • 04

    Oct

  • 04

    Oct

  • 23

    Oct

  • 27

    Oct

  • 10

    Nov

  • 30

    Nov

  • 15

    Jan

TWTR Twitter
$23.52

-0.48 (-2.00%)

10/04/16
SUSQ
10/04/16
NO CHANGE
Target $15
SUSQ
Neutral
Upside potential for Twitter takeout already captured, says Susquehanna
Susquehanna analyst Shyam Patil analyzed the potential takeout range for a Twitter buyout and believes most of the potential upside has already been captured. He sees the takeout range in the $17-$24 range and with the stock trading at $24, sees little upside. Patil recommends selling Twitter before market share losses to Snap play out as its fundamentals have deteriorated significantly since going public. Patil reiterated his Neutral rating and $15 price target on Twitter shares.
09/28/16
09/28/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Alphabet (GOOG, GOOGL) downgraded to Underperform from Neutral at Wedbush with analyst James Dix citing concerns that the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive. 2. AT&T (T) downgraded to Neutral from Buy at UBS with analyst John Hodulik citing expectations for lower earnings growth. 3. Macy's (M) downgraded to Neutral from Outperform at Credit Suisse with analyst Michael Exstein saying the retailer, after outlining in August its operations and merchandising strategies, is now in an execution phase. 4. Twitter (TWTR) downgraded to Underperform from Neutral at Mizuho and to Sell from Hold at Loop Capital. 5. Galectin Therapeutics (GALT) downgraded to Sell from Buy at Roth Capital with analyst Sa'ar Yaniv citing the company's announcement that NASH-FX, GR-MD-02's Phase 2a study in NASH fibrosis, failed both primary and secondary endpoints. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/28/16
SBSH
09/28/16
NO CHANGE
SBSH
Buy
Citi hopes Disney does not acquire Twitter
Citi analyst Jason Bazinet lays out four reasons for why he doesn't like Disney (DIS) pursuing an acquisition of Twitter (TWTR). Going back 15 years, the analyst can't think of a single web-based property that was successfully acquired by a traditional media firm. Two, he calls Twitter trends "troubling." Three, Bazinet estimates a cash offer would lower Disney's stock by $5 per share while an equity offer would drop its stock by $9. Four, the analyst feels it is unclear how Disney's content will help Twitter. Bazinet thinks both Yahoo (YHOO) and Twitter lost "significant money" when they streamed NFL content over the web. The analyst hopes Twitter is acquired by somebody other than Disney. He keeps a Buy rating on Disney shares. Both Loop Capital and Mizuho this morning downgraded Twitter to sell ratings.
09/28/16
MZHO
09/28/16
DOWNGRADE
Target $15
MZHO
Underperform
Mizuho cuts Twitter to Underperform with $15 price target
Mizuho analyst Neil Doshi downgraded Twitter to Underperform from Neutral based on valuation. The shares are up 45% since the company reported Q2 results, primarily driven by potential buyout comments in media reports, Doshi tells investors in a research note. The stock at current levels is overvalued as Twitter's business fundamentals "have deteriorated significantly" over the past 12 months, the analyst contends. Doshi believes many of the M&A scenarios are unlikely to play out. He puts potential acquirers Salesforce (CRM) and Alphabet (GOOG, GOOGL) in the "maybe" camp, but he still has some reservations about these deals happening. The analyst believes investors of both companies would view a buyout of Twitter as negative. Doshi keeps a $15 price target for Twitter shares. The stock closed yesterday up 35c to $23.72. Loop Capital this morning also downgraded Twitter to Sell.
CRM Salesforce
$72.63

2.11 (2.99%)

09/27/16
SBSH
09/27/16
NO CHANGE
Target $16
SBSH
Neutral
Citi sees 40% downside in Twitter with no takeover bid
Citi analyst Mark May believes Twitter's (TWTR) risk/reward skews to the downside following the recent rally in the shares. A buyout of the company carries "strategic rationale for certain companies," but Twitter's "struggles and steep valuation" make a deal at a meaningful premium less likely, May tells investors in a research note. A takeover at $26 per share looks aggressive, May contends. He believes the stock could retest the lows of late May, representing 40% downside from current levels, should an acquisition offer not materialize. The analyst keeps a Neutral rating on Twitter with a $16 price target. The shares closed yesterday up 75c to $23.37 following reports that Disney (DIS) may be joining the list of potential acquires that already includes Alphabet (GOOG) and Salesforce (CRM).
09/30/16
LEHM
09/30/16
NO CHANGE
Target $89
LEHM
Overweight
Barclays says Salesforce deserves a fresh look ahead of Dreamforce conference
Barclays analyst Raimo Lenschow said Salesforce (CRM) deserves a "fresh look" ahead of the Dreamforce conference and analyst day. The analyst said investor sentiment has weakened following slightly lower Q2 results and speculation it could acquire Twitter (TWTR). Lenschow said there is a low likelihood of a Twitter acquisition and expects revenue growth to reaccelerate in 2H FY17 and notes the company is still growing in the low 20% range. The analyst said Salesforce is near the bottom of its 10 year valuation range and reiterates his Overweight rating and $89 price target on shares.
10/03/16
BMOC
10/03/16
NO CHANGE
BMOC
Salesforce removed from US Large Cap Fundamental List at BMO Capital
GOOG Alphabet
$776.43

3.87 (0.50%)

09/27/16
WEDB
09/27/16
DOWNGRADE
WEDB
Underperform
Alphabet downgraded to Underperform from Neutral at Wedbush
Wedbush analyst James Dix downgraded Alphabet to Underperform and lowered his price target on shares to $700 on concerns the "Four Horsemen of the Search Apocalypse" -- self-identified consumers, consumer control of IP-delivered ads, payments innovation, and attention markets -- might arrive.
09/27/16
WEDB
09/27/16
DOWNGRADE
WEDB
Underperform
Alphabet downgraded to Underperform from Neutral at Wedbush
GOOGL Alphabet Class A
$802.79

2.41 (0.30%)

09/30/16
RBCM
09/30/16
NO CHANGE
RBCM
Street underestimating Google growth outlook, says RBC Capital
RBC Capital analyst Mark Mahaney expects Google to end 2016 with "up to 20% growth," versus the Street's outlook of mid teen percentage level growth. Mahaney says that Google's growth should be boosted by "ongoing Search innovations, rising Mobile CPCs, and the growing impact of YouTube, Play & Cloud." He thinks that YouTube's revenue is growing at a 30%-40% clip. Mahaney raised his price target on the stock to $1,025 from $1,000 and keeps an Outperform rating on the shares.
DIS Disney
$92.59

0.1 (0.11%)

09/26/16
09/26/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Disney (DIS) downgraded to Hold from Buy at Drexel Hamilton with analyst Tony Wible saying he believes a large step up in NBA costs, incremental subscribers losses, difficult studio comps, a riskier studio slate, and Shanghai cost pressures will weigh on fiscal 2017. 2. Twitter (TWTR) downgraded to Underperform from Perform at Oppenheimer with analyst Jason Helfstein saying a media company is the most likely acquirer of Twitter and would not pay meaningfully more than the valuation implied by our price target. 3. RetailMeNot (SALE) downgraded to Sell from Hold at Stifel with analyst Scott Devitt saying third party data indicates that the company's traffic trends have deteriorated recently. 4. Finish Line (FINL) downgraded to Neutral from Buy at Buckingham with the firm's analyst believing shares will be range bound in medium term due to high comp expectations, cost savings will be offset by incentive compensation and other investments, and less compelling valuation. 5. NetApp (NTAP) downgraded to Sell from Hold at Deutsche Bank with analyst Sherri Scribner saying secular challenges in the storage market are not reflected in NetApp's current valuation. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/26/16
UBSW
09/26/16
NO CHANGE
Target $92
UBSW
Neutral
Consumer satisfaction with competitors has caught up to Netflix, says UBS
UBS analyst Doug Mitchelson said that the firm's Evidence Lab survey indicated that U.S. consumer satisfaction with Amazon Prime Video (AMZN) and Hulu - the joint venture owned by Time Warner (TWX), Comcast (CMCSA), 21st Century Fox (FOXA), and Disney (DIS) - has now caught up to Netflix (NFLX), advising that investors should "continue to monitor competitive threats closely" as Netflix leads the category but demand for consumer media time, attention and wallet has intensified. The analyst, who added that Netflix's "pricing power remains unclear" based on the firm's survey work, keeps a Neutral rating and $92 price target on Netflix shares.

TODAY'S FREE FLY STORIES

ESRX

Express Scripts

$75.85

-0.88 (-1.15%)

, VRX

Valeant

$15.42

0.335 (2.22%)

13:06
12/08/16
12/08
13:06
12/08/16
13:06
Hot Stocks
Express Scripts drops after Citron compares to Valeant's Philidor »

Shares of Express Scripts…

ESRX

Express Scripts

$75.85

-0.88 (-1.15%)

VRX

Valeant

$15.42

0.335 (2.22%)

CVS

CVS Health

$79.80

-0.73 (-0.91%)

WBA

Walgreens Boots Alliance

$84.99

0.28 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Dec

  • 14

    Dec

  • 15

    Dec

  • 05

    Jan

  • 16

    Feb

YY

YY

$41.00

0.44 (1.08%)

13:05
12/08/16
12/08
13:05
12/08/16
13:05
Options
YY call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TLRD

Tailored Brands

$26.39

7.4597 (39.41%)

13:02
12/08/16
12/08
13:02
12/08/16
13:02
Hot Stocks
Tailored Brands surges as Jos. A. Bank turnaround gains traction »

Shares of Tailored Brands…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

GE

General Electric

$31.68

0.08 (0.25%)

13:01
12/08/16
12/08
13:01
12/08/16
13:01
Hot Stocks
GE Transportation acquires Iders Incorporated, terms not disclosed »

GE Transportation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

ESRX

Express Scripts

$75.85

-0.88 (-1.15%)

13:01
12/08/16
12/08
13:01
12/08/16
13:01
Periodicals
Citron cautious on Express Scripts, has $45 target on shares »

Citron Research tweeted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSY

Insys Therapeutics

$10.70

-0.54 (-4.80%)

12:57
12/08/16
12/08
12:57
12/08/16
12:57
Hot Stocks
Justice Department arrests former Insys executives, including CEO »

The U.S. Attorney's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MBOT

Microbot Medical

$7.75

-0.3 (-3.73%)

12:56
12/08/16
12/08
12:56
12/08/16
12:56
Hot Stocks
Breaking Hot Stocks news story on Microbot Medical »

Greenblock Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$19.39

-0.82 (-4.06%)

12:53
12/08/16
12/08
12:53
12/08/16
12:53
Recommendations
Horizon Pharma analyst commentary  »

BMO cuts Horizon Pharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

  • 08

    Dec

  • 14

    Dec

MLSS

Milestone Scientific

$1.77

-0.3254 (-15.50%)

12:51
12/08/16
12/08
12:51
12/08/16
12:51
Hot Stocks
Milestone Scientific: Henry Schein ahead of schedule in The Wand training »

Milestone Scientific…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTI

Universal Technical

$3.62

0.37 (11.38%)

12:44
12/08/16
12/08
12:44
12/08/16
12:44
Hot Stocks
Breaking Hot Stocks news story on Universal Technical »

Universal Technical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FEYE

FireEye

$13.61

0.41 (3.11%)

12:40
12/08/16
12/08
12:40
12/08/16
12:40
Options
FireEye calls active »

FireEye calls active. The…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Dec

12:40
12/08/16
12/08
12:40
12/08/16
12:40
General news
FX Action: USD-JPY »

FX Action: USD-JPY has…

UTI

Universal Technical

$3.62

0.37 (11.38%)

12:38
12/08/16
12/08
12:38
12/08/16
12:38
Hot Stocks
Breaking Hot Stocks news story on Universal Technical »

Universal Technical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTI

Universal Technical

$3.62

0.37 (11.38%)

12:38
12/08/16
12/08
12:38
12/08/16
12:38
Hot Stocks
Breaking Hot Stocks news story on Universal Technical »

Universal Technical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNST

Monster Beverage

$44.47

0.1 (0.23%)

12:35
12/08/16
12/08
12:35
12/08/16
12:35
Options
Monster Beverage put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PF

Pinnacle Foods

$51.04

0.58 (1.15%)

12:31
12/08/16
12/08
12:31
12/08/16
12:31
Conference/Events
Pinnacle Foods to hold an investor luncheon »

Investor Luncheon where…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTI

Universal Technical

$3.62

0.37 (11.38%)

12:30
12/08/16
12/08
12:30
12/08/16
12:30
Hot Stocks
Universal Technical: No pending non-public disclosures to account for stock rise »

Universal Technical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:30
12/08/16
12/08
12:30
12/08/16
12:30
General news
U.S. Household net worth rose »

U.S. Household net worth…

SAN

Banco Santander

$5.19

0.1549 (3.07%)

12:25
12/08/16
12/08
12:25
12/08/16
12:25
Options
Banco Santander call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:25
12/08/16
12/08
12:25
12/08/16
12:25
Conference/Events
Wells Fargo economists hold an analyst/industry conference call »

Chief Economist Silvia,…

TWTR

Twitter

$19.34

-0.14 (-0.72%)

12:21
12/08/16
12/08
12:21
12/08/16
12:21
Periodicals
Spotify cancels talks to acquire SoundCloud, TechCrunch says »

Spotify has pulled out of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIXG

Aixtron

$4.15

0.042 (1.02%)

12:17
12/08/16
12/08
12:17
12/08/16
12:17
Hot Stocks
Fujian Grand Chip cancels Aixtron takeover bid after U.S. intervention »

Grand Chip Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
12/08/16
12/08
12:16
12/08/16
12:16
Technical Analysis
NYSE market internals summary »

Breadth is bullish across…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:16
12/08/16
12/08
12:16
12/08/16
12:16
Technical Analysis
NASDAQ market internals summary »

Volume is lighter for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNC

PNC Financial

$114.46

1.79 (1.59%)

12:15
12/08/16
12/08
12:15
12/08/16
12:15
Options
PNC Financial put volume heavy and directionally bearish »

Bearish flow noted in PNC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.